Annual report pursuant to Section 13 and 15(d)

Note 9 - Accrued Liabilities

v3.24.1
Note 9 - Accrued Liabilities
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Accrued liabilities
9.
Accrued liabilities:

Accrued liabilities as of December 31, 2023 and December 31, 2022 consisted of the following:

 

 

December 31,
2023

 

 

December 31,
2022

 

Accrued personnel-related costs

 

$

1,989

 

 

$

2,302

 

Accrued research and development expenses

 

 

6,527

 

 

 

2,550

 

Other accrued expenses

 

 

313

 

 

 

233

 

Total

 

$

8,829

 

 

$

5,085